Expression of promyelocytic leukemia protein increases during the differentiation of human neuroblastoma cells

Virchows Archiv

Volumn 442, Issue 3, 2003, Pages 278-283

  Yu, Eunsil ^a   Choi, Eun Kyung ^a   Kim, Chong Jai ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Differentiation; Neuroblastoma; PML; Retinoic acid

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGY; BRAIN; CELL DIFFERENTIATION; CELL LINE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLIA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; INFANT; MALE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; REGULATORY MECHANISM; SYMPATHETIC GANGLION;

EID: 0037355463     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-002-0756-0     Document Type: Article

References (35)

1. Abemayor E, Sidell N (1989) Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation. Environ Health Perspect 80:3-15
2. Alcalay M, Tomassoni L, Colombo E, Stoldt S, Grignani F, Fagioli M, Szekely L, Helin K, Pelicci PG (1998) The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol 18:1084-1093
3. Borden KL, Campbell Dwyer EJ, Salvato MS (1997) The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain. FEBS Lett 418:30-34
4. Borrow J, Goddard AD, Sheer D, Solomon E (1990) Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249:1577-1580
5. Chan JY, Chin W, Liew CT, Chang KS, Johnson PJ (1998) Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues. Eur J Cancer 34:1015-1022
6. Cho Y, Lee I, Maul GG, Yu E (1998) A novel nuclear substructure, ND10: distribution in normal and neoplastic human tissues. Int J Mol Med 1:717-724
7. Cohen PS, Letterio JJ, Gaetano C, Chan J, Matsumoto K, Sporn MB, Thiele CJ (1995) Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cancer Res 55:2380-2386
8. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM (1994) A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333-343
9. Gambacorta M, Flenghi L, Fagioli M, Pileri S, Leoncini L, Bigerna B, Pacini R, Tanci LN, Pasqualucci L, Ascani S, Mencarelli A, Liso A, Pelicci PG, Falini B (1996) Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am J Pathol 149:2023-2035
10. Goddard AD, Borrow J, Freemont PS, Solomon E (1991) Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254:1371-1374
11. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pelicci PG (1993) The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423-431
12. Hodges M, Tissot C, Howe K, Grimwade D, Freemont PS (1998) Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am J Hum Genet 63:297-304
13. Kakizuka A, Miller WH, Umesono K, Warrell RP Jr, Frankel SR, Murty VV, Dmitrovsky E, Evans RM (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663-674
14. Kaplan DR, Matsumoto K, Lucarelli E, Thiele CJ (1993) Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of neuroblastoma cell lines. Neuron 11:321-331
15. Khan MM, Nomura T, Kim H, Kaul SC, Wadhwa R, Zhong S, Pandolfi PP, Ishii S (2001) PML-RARα alleviates the transcriptional repression mediated by tumor suppressor Rb. J Biol Chem 276:43491-43494
16. Koken MH, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thepot J, Juhlin L, Degos L, Calvo F, de The H (1995) The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10:1315-1324
17. Le XF, Vallian S, Mu ZM, Hung MC, Chang KS (1998) Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 16:1839-1849
18. Liu JH, Mu ZM, Chang KS (1995) PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J Exp Med 181:1965-1973
19. Lopez-Carballo G, Moreno L, Masia S, Perez P, Barettino D (2002) Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem 277:25297-25304
20. Lucarelli E, Kaplan DR, Thiele CJ (1995) Selective regulation of TrkA and TrkB receptors by retinoic acid and interferon-gamma in human neuroblastoma cell lines. J Biol Chem 270:24725-24731
21. Matsuo T, Thiele CJ (1998) p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line. Oncogene 16:3337-3343
22. Mu ZM, Chin KV, Liu JH, Lozano G, Chang KS (1994) PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 14:6858-6867
23. Mu ZM, Le XF, Vallian S, Glassman AB, Chang KS (1997) Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis 18:2063-2069
24. Nason-Burchenal K, Gandini D, Botto M, Allopenna J, Seale JR, Cross NC, Goldman JM, Dmitrovsky E, Pandolfi PP (1996) Interferon augments PML and PML/RARα expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoic acid resistant promyelocytic leukemia cell line. Blood 88:3926-3936
25. Pearson M, Pelicci PG (2001) PML interaction with p53 and its role in apoptosis and replicative senescence. Oncogene 20:7250-7256
26. Reddy BA, Etkin LD, Freemont PS (1992) A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem Sci 17:344-345
27. Ruggero D, Wang ZG, Pandolfi PP (2000) The puzzling multiple lives of PML and its role in the genesis of cancer. Bioessays 22:827-835
28. Terris B, Baldin V, Dubois S, Degott C, Flejou JF, Henin D, Dejean A (1995) PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res 55:1590-1597
29. Tonini R, Mancinelli E, Balestrini M, Mazzanti M, Marteganni E, Ferroni A, Sturani E, Zippel R (1999) Expression of Ras-GRF in the SK-N-BE neuroblastoma accelerates retinoic-acid-induced neuronal differentiation and increases the functional expression of the IRK1 potassium channel. Eur J Neurosci 11:959-966
30. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F, Pandolfi PP (1998) Role of PML in cell growth and the retinoic acid pathway. Science 279:1547-1551
31. Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R, Pandolfi PP (1998) Pml is essential for multiple apoptotic pathways. Nat Genet 20:266-272
32. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A (1994) Retinoic acid regulates aberrant nuclear localization of PML-RAR in acute promyelocytic leukemia cells. Cell 76:345-356
33. Zhang P, Chin W, Chow LT, Chan AS, Yim AP, Leung SF, Mok TS, Chang KS, Johnson PJ, Chan JY (2000) Lack of expression for the suppressor PML in human small cell lung carcinoma. Int J Cancer 85:599-605
34. Zhong S, Salomoni P, Pandolfi PP (2000) The transcriptional role of PML and the nuclear body. Nat Cell Biol 2:E85-E90
35. Zhong S, Salomoni P, Ronchetti S, Guo A, Ruggero D, Pandolfi PP (2000) Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. J Exp Med 191:631-640